Breast Cancer Clinical Trial
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts
Summary
500 patients will be prospectively recruited to undergo a fast breast MRI examination. The women will be recruited for the study will meet the following criteria: 1. African American 2. negative DBT examination 11 months prior to recruitment 3. Heterogeneously and Extremely breast densities 4. clinically asymptomatic- no palpable masses, focal thickening or clinically significant discharge. Investigators will identify these patients EPIC database utilizing the date of their last mammogram. Interested patients may contact our research coordinators by the phone number provided in the recruitment materials. The study recruitment information will also be shared with referring physicians. Physicians may also directly refer patients to the study.
Full Description
500 patients will be prospectively recruited to undergo an abbreviated or "FAST" breast MRI examination. The women will be recruited for the study must meet the following criteria: 1. African American 2. negative DBT examination no more than 11 months prior to the FAST MR 3. Heterogeneously and Extremely breast densities as graded on their most recent mammogram 4. clinically asymptomatic- no palpable masses, focal thickening or clinically significant nipple discharge. Investigators will identify these women via the EPIC database utilizing the date of their last mammogram. Interested women may contact our research coordinators by the phone number provided in the recruitment materials. The study recruitment information will also be shared with referring physicians. Physicians may also directly refer patients to the study.
Eligibility Criteria
Inclusion Criteria:
African American female
Negative DBT examination within eleven months prior to recruitment
Heterogeneoulsy and Extremely breast densities
Clinically asymptomatic- no palpable masses or focal thickening, etc.
Exclusion Criteria:
Patients who are pregnant and lactating
Patient who have not had a mammogram (DBT) in the past 11months
Patients who are unwilling or unable to provide written informed consent
Patients symptomatic for breast disease (e.g. experiencing discharge, lumps, ect.)
Recent breast surgery in the past 2 years including breast enhancements (e.g. implants or injections)
Patients who are unable to received an MRI with Gadolinium contrast
Patients who have not had an MRI of the breast with the past year
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Philadelphia Pennsylvania, 19104, United States More Info
Principal Investigator
How clear is this clinincal trial information?